CD8A and cancer: Although the presence of CD8+ cells among patients with MSI-H tumors does not seem to influence outcome [73], the ratio between CD8+, FOXp3+ and CD68+ cells and the presence of tumor budding has an independent effect on prognosis in both MSS and MSI-H cancers (Figure 3).